会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • SYSTEME PROMOTEUR
    • 系统推广
    • WO2007091073A1
    • 2007-08-16
    • PCT/GB2007/000441
    • 2007-02-07
    • F2G LTDBROMLEY, Michael, John
    • BROMLEY, Michael, John
    • C12N15/11C12N15/80
    • C12N15/111C12N2310/111C12N2310/14C12N2330/30
    • L'invention concerne une méthode d'expression d'une séquence polynucléotidique, qui consiste à exprimer cette séquence à partir d'une construction. Cette construction comprend ladite séquence liée de manière fonctionnelle à un promoteur présentant: i) une séquence d'ADN codant un promoteur fongique; ou ii) une séquence au moins à moitié identique à la séquence de i); ou iii) un fragment de i) ou de ii). Le système de l'invention met en oeuvre des méthodes améliorées de régulation contrôlée de gènes, qui permettent de rechercher un caractère essentiel, et donc de déterminer si un gène est une cible de médicament appropriée.
    • 发明协调组织多元化,包括éàer ette etteààà。。。。。。。。。。。。。。。。。 Cette建筑工程师laditeséquenceliéedemanièrefonctionnelleàun promoteurprésentant:i)uneséquenced'ADN codant un promoteur fongique; ou ii)uneséquenceau moinsàmoitiéidentiqueàlaséquencede i); ou iii)un fragment de i)ou de ii)。 Lesystèmede l'invent met en oeuvre desméthodesamélioréesderégulationcontrôléedegènes,qui permettent de rechercher uncaractèreessentiel,et donc dedéterminersi ungèneest une cible demédicamentstipée。
    • 4. 发明申请
    • 2031 OXIDOREDUCTASE
    • 2031氧化剂
    • WO2005080588A2
    • 2005-09-01
    • PCT/GB2005/000623
    • 2005-02-18
    • F2G LTDLAVENS, Sandra, ElizabethOLIVER, Jason, DavidTHAIN, John, LeslieTUCKWELL, Daniel, ScottBROMLEY, Michael, John
    • LAVENS, Sandra, ElizabethOLIVER, Jason, DavidTHAIN, John, LeslieTUCKWELL, Daniel, ScottBROMLEY, Michael, John
    • C12Q1/26
    • C12Q1/26C12Q1/18G01N2333/37G01N2333/90209G01N2500/02
    • Method of identifying an anti-fungal agent which targets an essential protein or gene of a fungus comprising contacting a candidate substance with (i) a NADH:flavin oxidoreductase protein which comprises the sequence shown by SEQ ID N0:3, (ii) a NADH:flavin oxidoreductase protein which is a homologue of (i) and which comprises the sequence shown by SEQ ID NO: 8, 12, 14, 19, 24, 42, 44, 83 or 85, (iii) a protein which has 50 % identity with (i) or (ii), (iv) a protein comprising a fragment of (i), (ii) or (iii) which fragment has a length of at least 50 amino acids, (v) a polynucleotide that comprises sequence which encodes (i), (ii), (iii) or (iv), (vi) a polynucleotide comprising sequence which has at least 70 % identity with the coding sequence of (v), and determining whether the candidate substance binds or modulates (i), (ii), (iii), (iv), (v) or (vi), wherein binding or modulation of (i), (ii), (iii), (iv), (v) or (vi) indicates that the candidate substance is an anti-fungal agent.
    • 鉴定靶向真菌的必需蛋白质或基因的抗真菌剂的方法,包括使候选物质与(i)包含SEQ ID NO:3所示序列的NADH:黄素氧化还原酶蛋白质接触, :(i)的同系物的黄素氧化还原酶蛋白,其包含SEQ ID NO:8,12,14,19,24,42,44,83或85所示的序列,(iii)具有50% 与(i)或(ii)的同一性,(iv)包含(i),(ii)或(iii)的片段的蛋白质,该片段长度为至少50个氨基酸,(v)包含序列 其编码(i),(ii),(iii)或(iv),(vi)包含与(v)的编码序列具有至少70%同一性的序列的多核苷酸,并确定候选物质是否结合或调节 (i),(ii),(iii),(iv),(v)或(vi)中的(i),(ii),(iii) vi)表示候选物质是抗真菌剂 。
    • 5. 发明申请
    • METHOD OF METAL DEPOSITION
    • 金属沉积方法
    • WO2012042203A2
    • 2012-04-05
    • PCT/GB2011001402
    • 2011-09-28
    • UNIV LANCASTERBOXALL COLINBROMLEY MICHAEL
    • BOXALL COLINBROMLEY MICHAEL
    • C23C18/18
    • H01L21/02697C23C18/14C23C18/1601C23C18/1603C23C18/1605C23C18/1642C23C18/1648C23C18/1667C23C18/1851C23C18/1879C23C18/31C23C18/44
    • A method of forming a metal layer on an electrically insulating substrate comprises depositing a photocatalyst layer onto the substrate and depositing a mask layer comprising voids on the substrate, such as a layer of latex microparticles with voids between them, to give an open pore structure to the mask. An electroless plating solution is then provided on the photocatalyst layer, and the photocatalyst layer and electroless plating solution are illuminated with actinic radiation whereby deposition of metal from the electroless plating solution to form a metal layer on the photocatalyst layer is initiated whereby the metal deposits in the voids of the mask layer. The mask layer is subsequently removed to leave a porous metal layer on the substrate. The method allows for deposition of porous metal films with controlled thickness and excellent adhesion onto electrically insulating substrates. The method is suitable for providing metal layers with controlled, regular porosity.
    • 在电绝缘衬底上形成金属层的方法包括将光催化剂层沉积到衬底上并将包含空隙的掩模层沉积在衬底上,例如在它们之间具有空隙的胶乳微粒层,以形成开孔结构 面具。 然后在光催化剂层上提供化学镀溶液,并且用光化辐射照射光催化剂层和化学镀溶液,由此开始从化学镀溶液中沉积金属以在光催化剂层上形成金属层,由此金属沉积在 掩模层的空隙。 随后去除掩模层以在基底上留下多孔金属层。 该方法允许沉积具有受控厚度的多孔金属膜和在电绝缘基底上的优异粘附性。 该方法适用于提供受控的,规则孔隙度的金属层。
    • 6. 发明申请
    • ANTI-FUNGAL TARGET GENES
    • 抗真菌目标基因
    • WO2005095975A3
    • 2006-03-23
    • PCT/GB2005001289
    • 2005-04-04
    • F2G LTDTUCKWELL DANIEL SCOTTBROMLEY MICHAEL JOHN
    • TUCKWELL DANIEL SCOTTBROMLEY MICHAEL JOHN
    • G01N33/569A61K39/00C07K14/37C07K14/38C07K16/14C12N15/80C12Q1/68
    • C07K14/38A61K39/00A61K2039/53G01N33/56961G01N2333/37G01N2333/38
    • Method of identifying an anti-fungal agent which targets an essential protein or gene of a fungus comprising contacting a candidate substance with (i) a protein which comprises the sequence shown by SEQ ID NOS: 3, 7, 11, 15, 19, 23, 27, 31, 35, 39, 43, 47, 51, 55, 59, 63, 67, 74, 78, 82, 86 or 90 (ii) a protein which has 50% identity with (i), (iii) a protein comprising a fragment of (i) or (ii) which fragment has a length of at least 50 amino acids, (iv) a polynucleotide that comprises sequence which encodes (i), (ii) or (iii), (v) a polynucleotide comprising sequence which has at least 70% identity with the coding sequence of (iv), and determining whether the candidate substance binds or modulates (i), (ii), (iii), (iv), or (v), wherein binding or modulation of (i), (ii), (iii), (iv), or (v) indicates that the candidate substance is an anti-fungal agent.
    • 鉴定靶向真菌的必需蛋白质或基因的抗真菌剂的方法,包括使候选物质与(i)包含SEQ ID NO:3,7,11,15,19,23所示序列的蛋白质接触 ,27,31,35,39,43,47,51,55,59,67,67,74,78,82,86或90(ii)与(i),(iii)具有50%同一性的蛋白质, 包含(i)或(ii)的片段的蛋白质,所述片段长度为至少50个氨基酸,(iv)多核苷酸,其包含编码(i),(ii)或(iii),(v) 包含与(iv)的编码序列具有至少70%同一性并确定候选物质是否结合或调节(i),(ii),(iii),(iv)或(v)的序列的多核苷酸, (i),(ii),(iii),(iv)或(v)的结合或调节表明候选物质是抗真菌剂。
    • 7. 发明申请
    • 2031 OXIDOREDUCTASE
    • WO2005080588A3
    • 2005-12-15
    • PCT/GB2005000623
    • 2005-02-18
    • F2G LTDLAVENS SANDRA ELIZABETHOLIVER JASON DAVIDTHAIN JOHN LESLIETUCKWELL DANIEL SCOTTBROMLEY MICHAEL JOHN
    • LAVENS SANDRA ELIZABETHOLIVER JASON DAVIDTHAIN JOHN LESLIETUCKWELL DANIEL SCOTTBROMLEY MICHAEL JOHN
    • C12Q1/18C12Q1/26
    • C12Q1/26C12Q1/18G01N2333/37G01N2333/90209G01N2500/02
    • Method of identifying an anti-fungal agent which targets an essential protein or gene of a fungus comprising contacting a candidate substance with (i) a NADH:flavin oxidoreductase protein which comprises the sequence shown by SEQ ID N0:3, (ii) a NADH:flavin oxidoreductase protein which is a homologue of (i) and which comprises the sequence shown by SEQ ID NO: 8, 12, 14, 19, 24, 42, 44, 83 or 85, (iii) a protein which has 50 % identity with (i) or (ii), (iv) a protein comprising a fragment of (i), (ii) or (iii) which fragment has a length of at least 50 amino acids, (v) a polynucleotide that comprises sequence which encodes (i), (ii), (iii) or (iv), (vi) a polynucleotide comprising sequence which has at least 70 % identity with the coding sequence of (v), and determining whether the candidate substance binds or modulates (i), (ii), (iii), (iv), (v) or (vi), wherein binding or modulation of (i), (ii), (iii), (iv), (v) or (vi) indicates that the candidate substance is an anti-fungal agent.
    • 鉴定靶向真菌必需蛋白质或基因的抗真菌剂的方法,包括使候选物质与(i)包含SEQ ID NO:3所示序列的NADH:黄素氧化还原酶蛋白质,(ii)NADH :黄素氧化还原酶蛋白质,其是(i)的同源物并且包含SEQ ID NO:8,12,14,19,24,42,44,83或85所示的序列,(iii)具有50% (i)或(ii)的同一性,(iv)包含(i),(ii)或(iii)的片段的蛋白质,该片段具有至少50个氨基酸的长度,(v)包含序列 ()),(ⅱ),(ⅲ)或())的多核苷酸,())包含与())的编码序列具有至少70%同一性的序列的多核苷酸,并确定候选物质是否结合或调节 (i),(ii),(iii),(iv),(v)或(vi) vi)表示候选物质是抗真菌剂 。